Parvovirus B19 Presenting with Severe Sepsis in a Previously Healthy 25-year-old Female

References

1. ↵
   Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group. JAMA 1997; 278: 234–40.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   Mermel LA, Maki D. Detection of bacteremia in adults: consequences of culturing an inadequate volume of blood. Ann Intern Med 1993; 119: 270.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   ACCP: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; DA-19920706(6): 864–74.

   OpenUrl
4. ↵
   Pamuk ON, Pamuk GE, Celik AF, Ozturk R, Aktuglu Y. Herpes simplex virus esophagitis in an immunocompetent host with sepsis. Am J Gastroenterol 2001; 96: 2264–6

   OpenUrl
5. Muhe L, Tilahun M, Lulseged S, et al. Etiology of pneumonia, sepsis and meningitis in infants younger than three months of age in Ethiopia. Pediat Infect Dis J 1999; 18(10 Suppl): S56–61.

   OpenUrl
6. Gatchalian SR, Quiambao BP, Morelos AM, et al. Bacterial and viral etiology of serious infections in very young Filipino infants. Pediat Inf Dis J. 1999; 18(10 Suppl): S50–5.

   OpenUrl
7. ↵
   Wenzel RP, Pinsky MR, Ulevitch RJ, Young L. Current understanding of sepsis. Clin Infect Dis 1996; 22: 407–12.

   OpenUrlFREE Full Text
8. ↵
   Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6: 711–8.

   OpenUrlPubMedWeb of Science
9. ↵
   Hayakawa H, Tara M, Niina K, Osame M. A clinical study of adult human parvovirus B19 infection. Intern Med 2002; 41: 295–9.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Torok, TJ. Unusual clinical manifestations reported in patients with parvovirus B19 infection. In: Anderson LJ, Young NS, editors. Monographs in virology: human parvovirus B19. New York: Karger; 1997. p. 61.
11. ↵
    Mortimer PP, Humphries RK, Moore JG, et al. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 1983; 302: 426–9.

    OpenUrlCrossRefPubMed
12. ↵
    Erdman DD. Human parvovirus B19: laboratory diagnosis. In: Anderson LJ, Young NS, editors. Monographs in virology: human parvovirus B19. New York: Karger; 1997. p. 93.
13. ↵
    Erdman DD, Usher J, Tsou C, et al. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J Med Virol 1991; 35: 110–5.

    OpenUrlPubMed
14. ↵
    Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997; 53: 229–32.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    Soderlund M, von Essen R, Haapasarri J, et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063–5.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    Case definitions for infectious conditions under public health surveillance. Morb Mortal Wkly Rep 1997; 46: 39.

    OpenUrl